Stocks Clock Fourth...
Health Care: Drugs
Cardiome Pharma Corporation (CRME: NASDAQ)
$2.15 0.03 | 1.42%
05/17/13 - 03:51 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -18.32M | -27.92M | 35.50M | -1.22M |
| Operating Gains/Losses | 0.00 | 34.00K | 0.00 | 4.24M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 270.00K | -506.00K | 711.00K | -1.19M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 2.01M | -2.49M | -1.91M | -2.19M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | -35.20M | 35.33M |
| Other Non-Cash Items | -10.31M | 1.81M | 2.93M | 3.54M |
| Net Cash From Continuing Operations | -25.10M | -27.61M | 2.68M | 42.39M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -25.10M | -27.61M | 2.68M | 42.39M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -433.00K | -1.02M | -584.00K | -117.47K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -433.00K | -1.02M | -584.00K | -117.47K |
| Issuance of Debt | 25.00M | 0.00 | 25.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 0.00 | 358.00K | 2.36M | 3.01M |
| Repayment of Long-Term Debt | -7.00M | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | -28.25M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 70.00K | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 18.07M | 358.00K | 27.36M | -25.24M |
| Effect of Exchange Rate Changes | 84.00K | 26.00K | 166.00K | -5.06M |
| Net Change in Cash & Cash Equivalents | -7.38M | -28.24M | 29.62M | 11.97M |
Portfolios with CRME
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- UserUBS Portfoglio Fall 2008
- UserKathleen Futey Portfolio 1
- Userkimtdallas Portfolio 1
- ContributorStockerblog.com Canadian Li...
- Usergrtdane Portfolio 1
- Userjack stern Portfolio 1
- Userpanda33 Portfolio 1
- UserJRT Portfolio 1
- Userirvgruve Portfolio 1
Latest CRME Headlines from TheStreet
- Cardiome Reaches Agreement With Merck To Retire Debt And Close Line Of Credit 12.11.12 | 08:12 am
- Cardiome To Hold Conference Call 09.26.12 | 08:09 am
- Merck Returns Global Marketing And Development Rights For Vernakalant To Cardiome 09.26.12 | 08:09 am
- Cardiome Announces Appointment Of Jennifer Archibald As Chief Financial Officer 09.20.12 | 04:09 pm
- Cardiome Notes Updated Guidelines From European Society Of Cardiology Now Include Brinavess(TM) (Vernakalant) For Infusion 09.10.12 | 08:09 am
- Cardiome To Hold Investor Update Call 08.21.12 | 04:08 pm
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- Cardiome Pharma Corp. (CRME): Today's Featured Health Care Loser 09.29.11 | 04:09 pm
- Cardiome Pharma Corp. Stock Downgraded (CRME) 09.05.11 | 08:09 am
- Cardiome Stock Gaps Up On Today's Open (CRME) 07.26.11 | 09:07 am
Press Releases for CRME
- Cardiome Reports First Quarter Results - PR Newswire 05.13.13 | 09:05 am
- Cardiome To Present At Bloom Burton & Co. Healthcare Investor Conference - PR Newswire 05.10.13 | 07:05 am
- Cardiome Announces The Addition Of Dr. Steen Juul-Möller As Medical Director, Europe - PR Newswire 03.28.13 | 07:03 am
- Cardiome Announces Changes To Senior Management Team - PR Newswire 03.26.13 | 07:03 pm
- Independent Proxy Advisor Firms ISS And Glass Lewis Recommend Cardiome Shareholders Vote In Favor Of Share Consolidation - PR Newswire 03.19.13 | 04:03 pm
- Cardiome Reports Fourth Quarter And Full Year 2012 Financial Results - PR Newswire 03.15.13 | 07:03 am
- Cardiome To Hold Fourth Quarter And Full Year 2012 Financial Results Conference Call On March 15 - PR Newswire 03.12.13 | 02:03 pm
- Cardiome Announces Settlement Of Debt And Termination Of Line Of Credit With Merck - PR Newswire 03.04.13 | 08:03 am
- Cardiome Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BRINAVESSâ¿¢ (Vernakalant Intravenous) - PR Newswire 02.04.13 | 04:02 pm
- Cardiome Announces Management Change - PR Newswire 07.03.12 | 12:07 pm
Partner Headlines for CRME
- Cardiome Announces CEO Doug Janzen Has Left Company - Benzinga 07.03.12 | 12:07 pm
- Diana Containerships: High-Yield Dividend Play With Mid-Term Charters - Seeking Alpha 07.03.12 | 09:07 am
- Morning Market Losers - Benzinga 03.19.12 | 09:03 am
- Morning Market Movers - Benzinga 12.29.11 | 09:12 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 11.09.11 | 09:11 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 10.27.11 | 09:10 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 10.27.11 | 09:10 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 07.11.11 | 09:07 am
- Flat Finish Friday, But Stocks End Week Sharply Lower - Seeking Alpha 06.25.10 | 04:06 pm
- 25 Momentum Stocks for Tuesday - SeekingAlpha.com 04.06.10 | 03:04 am
